首页> 外国专利> EST clones differetially expressed in hepatocellular carcinoma which are applicable for diagnostic probe, bio-chip, or gene-therapy

EST clones differetially expressed in hepatocellular carcinoma which are applicable for diagnostic probe, bio-chip, or gene-therapy

机译:在肝细胞癌中差异表达的EST克隆可用于诊断探针,生物芯片或基因治疗

摘要

PURPOSE: EST(expressed sequence tag) clones differentially expressed in hepatocellular carcinoma and the use thereof are provided, The EST clones can be useful for diagnosis and treatment of cancer. CONSTITUTION: The EST(expressed sequence tag) clones differentially expressed in hepatocellular carcinoma comprise clone HA61T2(KCTC 10043BP) having the nucleotide sequence of SEQ ID NO: 1, PT18(KCTC 10044BP) having the nucleotide sequence of SEQ ID NO: 2, HG63T1(KCTC 10045BP) having the nucleotide sequence of SEQ ID NO: 3, HG57T1(KCTC 10046BP) having the nucleotide sequence of SEQ ID NO: 4, DNT10(KCTC 10047BP) having the nucleotide sequence of SEQ ID NO: 5 and PT8(KCTC 10048BP) having the nucleotide sequence of SEQ ID NO: 6. The EST clones differentially expressed in hepatocellular carcinoma are applied to diagnostic probe, bio-chip or gene-therapy.
机译:目的:提供在肝细胞癌中差异表达的EST(表达序列标签)克隆及其用途。EST克隆可用于癌症的诊断和治疗。组成:在肝细胞癌中差异表达的EST(表达序列标签)克隆包括具有核苷酸序列SEQ ID NO:1的克隆HA61T2(KCTC 10043BP),具有核苷酸序列SEQ ID NO:2的PT18(KCTC 10044BP),HG63T1 (KCTC 10045BP)具有SEQ ID NO:3的核苷酸序列,HG57T1(KCTC 10046BP)具有SEQ ID NO:4的核苷酸序列,DNT10(KCTC 10047BP)具有SEQ ID NO:5的核苷酸序列和PT8(KCTC) 10048BP)具有SEQ ID NO:6的核苷酸序列。在肝细胞​​癌中差异表达的EST克隆被用于诊断探针,生物芯片或基因治疗。

著录项

  • 公开/公告号KR100435230B1

    专利类型

  • 公开/公告日2004-06-09

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20010052213

  • 发明设计人 김대곤;유경란;

    申请日2001-08-28

  • 分类号C12N15/10;

  • 国家 KR

  • 入库时间 2022-08-21 22:47:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号